The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| AFCNX | RERFX | AFCNX / RERFX | |
| Total Expense Ratio | 1.10 | 0.52 | 212% |
| Annual Report Gross Expense Ratio | 1.10 | 0.52 | 212% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | -2.055 | 6.166 | -33% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 189M | 137B | 0% |
| Annual Yield % from dividends | 0.02 | 2.67 | 1% |
| Returns for 1 year | 1.66 | 7.80 | 21% |
| Returns for 3 years | 22.53 | 26.18 | 86% |
| Returns for 5 years | -12.58 | -4.83 | 261% |
| Returns for 10 years | 82.34 | 46.46 | 177% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPZ | 13.14 | 0.06 | +0.46% |
| Calamos Long/Short Equity & Dynamic Income Trust | |||
| LODI | 25.11 | 0.02 | +0.08% |
| AAM SLC Low Duration Income ETF | |||
| QIG | 43.45 | N/A | N/A |
| WisdomTree US Corporate Bond | |||
| DSL | 10.54 | -0.04 | -0.38% |
| DOUBLELINE Income SOLUTIONS FUND | |||
| LABD | 6.28 | -0.22 | -3.38% |
| Direxion Daily S&P Biotech Bear 3X ETF | |||